Novo Nordisk selling vitamin/OTC unit Ferrosan to management buy-out group.
This article was originally published in The Tan Sheet
Executive Summary
FERROSAN ACQUIRED FROM NOVO NORDISK IN MANAGEMENT BUY-OUT, Copenhagen, Denmark-based Novo Nordisk announced Nov. 6. Novo Nordisk reported that it has agreed to sell a controlling interest in its Ferrosan vitamin and OTC products business in Europe to a management group for 400 mil. Danish kroner.